Murat BİCAKCİOGLU, Said YİLDİRİM, Abdullah GOK, Ahmet YARDIM, Mehmet Özcan ERSOY

Anesthetic Management of Children with Moyamoya Disease: A Case Report

Moyamoya disease is a cerebrovascular disease named after its angiographic image diagnosis, the etiology of which is not known and which is characterized by the chronic progressive stenosis of the main internal cerebral arteries that make up the Willis polygon. Ischemic symptoms are at the forefront in this disease which is more frequently observed in children. The definitive treatment of this disease is surgery and cerebral ischemia is a complication that can develop frequently during surgery. That is why, care during the perioperative period is very important. Perioperative anesthetic goal is to ensure the balance between the delivery of oxygen to the brain and the consumption of oxygen. The objective of this presentation is to discuss the anesthesia application in a child case who underwent encephalo-dura-arterio-cynangiozis (EDAS) surgery because of a 15 month moyamoya disease.

PDF

___

Bıkmaz K, Coşar M, Başocak K, Bek Ş, İplikçioğlu AC. The use of multiple burr-hole operation for cerebral revascularization in a seven-year-old child with mayamaya disease. Türk Nöroşir Derg. 2004;14(1):59-63.

Aydoğan MS, Yücel A, Özgül Ü, Öztürk E, Konur H, Öztanır MN, Ersoy MÖ. Anesthetic approach to aduit moyamoya disease: a case report. Gülhane Tıp Derg. 2010;52(3):212-5.

Karabağlı H, Etuş V. Moyamoya disease. Türk Nöroşir Derg. 2013;23(2):141-9.

Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg. 1993;77(5):1066-70.

Keleş GT, Topçu İ, Canan S, Ağdanlı D. Moyamoya disease and anesthesia: TIVA & VIMA. Göztepe Tıp Derg. 2013;28(2):95-100.

Hee-Soo Kim. Moyamoya disease and anesthesia in children. In: Cho BK, Tominaga T. Moyamoya Disease Update. Springer. 2010:234-40.

Parray T, Martin TW, Siddiqui S.Moyamoya disease: A review of the disease and anesthetic Management. J Neurosurg Anesthesiol. 2011;23(2):100-9.

Jaffe RA, Lopez JR, McGregor DG. Anesthetic and perioperative management of moyamoya disease. İn: Wanebo JE, Khan N, Zabramski J. Moyamoya Disease: Diagnosis and Treatmend. New York: Thieme Medical Publishers, Inc. 2014:157-66.

Parray T, Martin TW, Siddiqui S.Moyamoya disease: A review of the disease and anesthetic Management. J Neurosurg Anesthesiol. 2011;23(2):100-9.

Baykan N, Özgen S, Ustalar S, Dağçınar A, Özek M. Moyamoya disease and anesthesia. Pediatric Anesthesia. 2005;15(12):1111-5.

Tagawa T, Naritomi H, Mimaki T, Yabuuchi H, Sawada T. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke. 1987;18(5):906-10.

Machado SB, Mendes FF, Angelini AC. Moyamoya disease and sevoflorane anesthesia outside the surgery center: case report. Rev Bras Anestesiol. 2002;52(3):344-7.

Kurehara K, Ohnishi H, Touho H, Furuya H, Okuda T. Cortical blood flow response to hypercapnia during anaesthesia in moyamoya disease. Can J Anaesth. 1993;40(8):709-13.

Chiu D, Peter Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke. 1998:29(7):1347-51.

Sato K, Shirane R, Yoshimato T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Child's Nerv Syst. 1997;13(2):68-72.

Kim J, Jang GD, Kim DS, Min KT. Small dose of propofol combine with dexametazone for postoperative vomiting in pediatric Moyamoya disease patients: a prospective, observed-blinded, randomized controlled study. Korean Anesth. 2013;64(2):127-32.